Walgreens Boots Alliance Inc (NASDAQ:WBA) Receives $63.65 Average PT from Brokerages

Walgreens Boots Alliance Inc (NASDAQ:WBA) has been assigned a consensus recommendation of “Hold” from the twenty-four analysts that are covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokers that have covered the stock in the last year is $63.65.

Several research analysts recently weighed in on the company. Morgan Stanley dropped their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Bank of America dropped their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research note on Monday, June 3rd. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. JPMorgan Chase & Co. dropped their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research note on Friday, June 28th. Finally, BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 11th.

WBA stock traded up $0.61 on Friday, hitting $55.18. 2,500,589 shares of the company’s stock were exchanged, compared to its average volume of 4,500,405. Walgreens Boots Alliance has a 12-month low of $49.03 and a 12-month high of $86.31. The firm has a 50 day moving average price of $52.37 and a two-hundred day moving average price of $54.62. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76. The stock has a market cap of $49.53 billion, a P/E ratio of 9.17, a price-to-earnings-growth ratio of 1.37 and a beta of 0.88.



Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The firm had revenue of $34.59 billion for the quarter, compared to the consensus estimate of $34.52 billion. During the same period in the previous year, the business earned $1.53 EPS. The firm’s revenue for the quarter was up .7% on a year-over-year basis. Sell-side analysts expect that Walgreens Boots Alliance will post 5.98 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th were given a dividend of $0.458 per share. The ex-dividend date was Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a yield of 3.32%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s payout ratio is currently 30.40%.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the completion of the sale, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 15.73% of the company’s stock.

Hedge funds have recently modified their holdings of the company. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in Walgreens Boots Alliance by 19.1% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 184,921 shares of the pharmacy operator’s stock worth $10,110,000 after purchasing an additional 29,623 shares during the period. EP Wealth Advisors LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter worth about $223,000. Toronto Dominion Bank raised its holdings in Walgreens Boots Alliance by 30.0% in the 2nd quarter. Toronto Dominion Bank now owns 923,186 shares of the pharmacy operator’s stock worth $50,458,000 after purchasing an additional 213,130 shares during the period. American International Group Inc. raised its holdings in Walgreens Boots Alliance by 43.7% in the 2nd quarter. American International Group Inc. now owns 631,923 shares of the pharmacy operator’s stock worth $34,547,000 after purchasing an additional 192,173 shares during the period. Finally, Nomura Holdings Inc. raised its holdings in Walgreens Boots Alliance by 44.2% in the 2nd quarter. Nomura Holdings Inc. now owns 24,562 shares of the pharmacy operator’s stock worth $1,341,000 after purchasing an additional 7,528 shares during the period. 59.70% of the stock is owned by institutional investors and hedge funds.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: How is diluted EPS different from basic EPS?

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.